Sunday, October 13, 2019 6:18:03 PM
I highly recommend you check out Dr. Weissberg’s presentation at the CANB Shareholder Meeting:
I have included Dr. Weissberg’s Bio below, but I encourage you to read the bios of Canbiola’s entire medical and corporate advisory boards, which are stacked with 8 MDs, 4 attorneys, NFL great Leonard Marshall and 1 Senator:
https://canbiola.com/management-team/
Dr. David Weissberg is a very active Board Certified Orthopedic surgeon who has multiple offices throughout Suffolk County Long Island, New York. Dr. Weissberg grew up in Huntington, New York where his main office is located. After graduating Huntington High School he earned a Bachelor of Science degree from Stony Brook University where he graduated Cum Laude. He went on to attend Downstate Medical School where he was inducted into the Alpha Omega Alpha Honor Society. After completing his General Surgical internship at Kings County Hospital he did a 4 year residency in Orthopedic Surgery at Stony Brook University. Dr. Weissberg initially went into private practice in Huntington, New York. During that time he served as the President of The Huntington Medical Group as well as being the football team physician for the Huntington, Walt Whitman and Northport school districts. Dr. Weissberg developed and was the CEO of Long Island Physicians Holdings Company which created and managed Long Islands' first physician own medical insurance company in the 1990's. Later Dr. Weissberg was brought on initially to the Board of Directors and then CEO of a publicly traded Biotech company Cytocore Inc. Additionally, Dr. Weissberg served as President and other roles as an officer at the Melville Surgery Center. Dr. Weissberg has always maintained a strong interest in the biotechnological aspect of medicine. His practice in addition to his surgical treatments also uses a great deal of Orthobiologic solutions for his patients. These treatments include his use of Stem Cells, Platelet Rich Plasma, Embryonic tissue and Viscosupplementation procedures to provide excellent non surgical outcomes for his patients. Dr. Weissberg was brought on by the company MarijuanaDoctors.com as a medical adviser and was instrumental in developing a CME course to educate physicians on the use Medical Marijuana in New York State. Dr. Weissberg has been using Canbiola CBD products in his practice and has found it to provide excellent relief for many of his patients Orthopedic needs including it's uses for pain, swelling, inflammation and neuropathies.
Sleek
SLEEKSCAPE’S GRAND SALAMI FOR 2020 HEMP & CBD MANIA -- PART II
https://investorshub.advfn.com/$LEEK$CAPE’S-2019-HEMP-CBD-&-MARIJUANA-MANIA-GRAND-SALAMI-PART-II-31243/
Recent CANB News
- Can B Corp. Secures Ownership and Control of Two Cannabis Patents Valued at $122 Million and Potentially in Excess of $750 Million • InvestorsHub NewsWire • 03/11/2024 12:34:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 10:15:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/01/2024 10:02:41 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 09:38:08 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 04:52:26 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/08/2024 06:08:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2024 12:52:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 03:36:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 10:15:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:18:08 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/13/2023 02:44:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 06:24:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2023 08:57:21 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 09:12:43 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:41:28 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM